Sichuan Biokin Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 1,625.59% vs 64.62% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 203.73% vs -221.73% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,894.70",
          "val2": "109.80",
          "chgp": "1,625.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "948.00",
          "val2": "-418.70",
          "chgp": "326.42%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "24.40",
          "val2": "11.10",
          "chgp": "119.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.50",
          "val2": "-2.10",
          "chgp": "171.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "623.40",
          "val2": "-601.00",
          "chgp": "203.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "500.40%",
          "val2": "-4,012.50%",
          "chgp": "451.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 944.74% vs -19.88% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 575.02% vs -176.38% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,819.20",
          "val2": "557.00",
          "chgp": "944.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,760.40",
          "val2": "-731.50",
          "chgp": "614.07%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "43.90",
          "val2": "25.40",
          "chgp": "72.83%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "11.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,707.50",
          "val2": "-780.50",
          "chgp": "575.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "631.90%",
          "val2": "-1,433.60%",
          "chgp": "206.55%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

1,894.70

109.80

1,625.59%

Operating Profit (PBDIT) excl Other Income

948.00

-418.70

326.42%

Interest

24.40

11.10

119.82%

Exceptional Items

1.50

-2.10

171.43%

Consolidate Net Profit

623.40

-601.00

203.73%

Operating Profit Margin (Excl OI)

500.40%

-4,012.50%

451.29%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 1,625.59% vs 64.62% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 203.73% vs -221.73% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

5,819.20

557.00

944.74%

Operating Profit (PBDIT) excl Other Income

3,760.40

-731.50

614.07%

Interest

43.90

25.40

72.83%

Exceptional Items

11.40

0.00

Consolidate Net Profit

3,707.50

-780.50

575.02%

Operating Profit Margin (Excl OI)

631.90%

-1,433.60%

206.55%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 944.74% vs -19.88% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 575.02% vs -176.38% in Dec 2023

All Annual Results